| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $177.3M | -19.5% |
| Cost of Revenue | $114.4M | -24.5% |
| Gross Profit | $62.9M | -8.6% |
| R&D Expense | $39.3M | -26.5% |
| SG&A Expense | $26.0M | -5.1% |
| Operating Income | -$70.4M | -15.7% |
| Interest Expense | $5.8M | +131.8% |
| Pre-tax Income | -$76.3M | -19.9% |
| Income Tax | -$1.9M | -113.5% |
| Net Income | -$74.5M | +3.8% |
| EPS (Basic) | -$2.65 | +5.7% |
| EPS (Diluted) | -$2.65 | +5.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $40.4M | -37.0% |
| Inventory | $42.0M | -37.2% |
| Current Assets | $136.5M | -16.0% |
| Total Assets | $173.7M | -20.3% |
| Current Liabilities | $135.9M | +41.1% |
| Long-term Debt | $67.6M | +169.3% |
| Total Liabilities | $177.0M | +29.2% |
| Stockholders' Equity |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.0M | +11.7% |
| Capital Expenditures | $6.4M | +39.5% |
| Investing Cash Flow | -$11.9M | -6.0% |
| Financing Cash Flow | $43.2M | +3502.9% |
| Free Cash Flow | -$21.4M | +0.8% |
| -$3.2M |
| -104.0% |